JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiss, W. P.
Right arrow Articles by Sokoloff, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, W. P.
Right arrow Articles by Sokoloff, L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 136, Issue 3, 366-371, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF SALICYLATE ON AMINO ACID INCORPORATION INTO PROTEIN

William P. Weiss 1, Phyllis L. Campbell 1, Gladys E. Deibler 1, and Louis Sokoloff 1

1 Section on Cerebral Metabolism, Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, U. S. Department of Health, Education and Welfare, Public Health Service, Bethesda, Maryland

Salicylate, like thyroxine, stimulates amino acid incorporation into protein in cell-free rat liver homogenates. The optimal concentration is approximately 3 x 10-3 M in preparations from euthyroid rats. The maximum effect is moderately lower than that of thyroxine, and equivalent effects are obtained with salicylate concentrations approximately twenty times that of thyroxine. Like the thyroxine effect, the action of salicylate is decreased in liver preparations from thyroidectomized rats. Although the actions of thyroxine and salicylate on this process are similar, there is no significant potentiation of the effects of one by the other. The mechanism of the salicylate effect differs in at least one important respect from that of thyroxine; it is not dependent on the presence of mitochondria and an oxidizable substrate and is observed when these components are replaced by a creatine phosphate-ATP generating system.

Submitted on January 22, 1962







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.